Venture Capital Firms in California

111° West Capital is a multi-stage investment firm that partners with commercial-stage enterprise software companies focused on transforming healthcare delivery and operations.The firm combines a dedicated investment team with an Operator network to provide a hands-on, growth-oriented approach intended to accelerate revenue, scale operations and drive successful exits for portfolio companies.111° West Capital’s public materials and industry profiles indicate a primary focus on digital health and enterprise healthcare software investments, and that the firm was founded in 2021 and is active across stages from commercial growth rounds through Series A/B in its areas of expertise.

137 Ventures is a San Francisco‑based private investment firm specializing in providing liquidity solutions and growth capital to founders, early employees and angel investors in high‑growth technology companies. Founded in 2011, the firm manages over US$5 billion across funds that purchase private company shares on the secondary market and participate in primary growth rounds. 137’s approach allows early stakeholders to realize liquidity without forcing a premature sale or IPO, while enabling companies to continue compounding value privately. Its portfolio includes some of Silicon Valley’s most iconic names in enterprise software, fintech, consumer internet and mobility. In addition to capital, the firm offers strategic support, including introductions to later‑stage investors, guidance on secondary market dynamics and advice on navigating complex cap‑table structures. The team maintains strict confidentiality and aims to align with both founders and early shareholders by structuring transactions that work for all parties. 137 Ventures’ culture emphasizes long‑term thinking, integrity and the belief that providing liquidity at the right time can be a catalyst for innovation, allowing founders and employees to focus on building rather than managing personal finances.

1984 Ventures is a venture capital firm founded in 2017 and headquartered in San Francisco, California. Inspired by Apple’s iconic “1984” Macintosh launch, the firm champions the belief that nimble, software-driven startups can challenge and transform industry incumbents. The firm invests primarily at the pre-seed and seed stages, focusing on founders with grit, industry insights, and strong engineering culture. 1984 Ventures operates with a collaborative, founder-friendly approach, typically investing via SAFE or equity without taking board seats. The firm provides hands-on support in recruiting, fundraising, and preparing portfolio companies for successful Series A rounds. It also publishes a public Founders Handbook to guide early-stage teams on topics ranging from cap tables to Series A preparation and open-source strategy. The firm’s portfolio includes over 120 investments, with notable companies such as Fairmarkit, Reggora, BuildOps, Convex, Kyte, and PadSplit. 1984 Ventures has achieved multiple exits and continues to back innovative startups across sectors like SaaS, AI, fintech, proptech, logistics, and healthcare, with a strong presence in the United States and selective investments in Europe and Latin America.

1Flourish Capital is a venture capital firm focused on investing in early-stage, disruptive technology startups led by founders of high character who are on missions to advance human flourishing. Beyond providing capital, 1Flourish actively supports its portfolio companies through strategic guidance, leadership training, and cultivating exceptional company cultures based on principles such as trust, humility, and accountability. Their approach emphasizes building enduring values and sustainable success in their investments. The firm leverages the expertise of advisors like Patrick Lencioni and The Table Group to help founders develop strong leadership and governance practices. 1Flourish’s team has extensive experience managing over $1 billion in venture capital and private equity, with backgrounds including serial entrepreneurship, technology leadership, and operational excellence. This deep operational and investment experience enables them to nurture portfolio companies effectively. 1Flourish primarily invests in the United States, focusing on sectors such as e-commerce and enterprise technology. Their investment style is collaborative and operator-led, emphasizing disciplined scaling of innovative businesses. The firm is known for its commitment to principled leadership and high-performance company cultures, aiming to back visionary technical founders poised to scale solutions that enhance human well-being.

2AM VC is an early-stage venture capital firm with a distinctive focus on India's burgeoning startup ecosystem. Established in 2021, the firm positions itself as a sector-agnostic investor, primarily targeting Gen Z-centric companies. They are dedicated to supporting young and first-time Indian founders, believing in India's potential to become the next Silicon Valley. The firm emphasizes speed, transparency, and a founder-friendly approach, often acting as lead investors and deploying capital rapidly through various instruments like iSafe, SAFE, convertible notes, and priced rounds.The firm was co-founded by Brendan Rogers and Hershel Mehta, who bring a blend of entrepreneurial experience and investment acumen. Brendan Rogers is known for his optimistic view on India's startup narrative and his background as a founder, while Hershel Mehta connects Silicon Valley networks with the Indian startup landscape, drawing from a family legacy in entrepreneurship and investing. 2AM VC launched its debut fund in 2021, which closed at $10 million, and is currently raising its second fund with a target of $25 million to continue investing in Indian startups at the pre-seed and seed stages.2AM VC boasts a diverse portfolio of over 59 companies, reflecting its sector-agnostic strategy. Notable investments include Karbon Card and Bluelearn, with other portfolio companies spanning various sectors such as NewMe (clothing), ApnaMart (department stores), Bimaplan (financial software), Zepto (a unicorn in their portfolio), Krave Mart, Coolberg, Attryb, Goldsetu, and Mekr. Their investments cover areas like e-commerce, fintech, wellness, mental health, fitness, crypto, non-fungible tokens, enterprise applications, consumer retail, and artificial intelligence.The 2AM VC team comprises experienced individuals, including Co-Founders & Partners Brendan Rogers and Hershel Mehta, Venture Partner Vatsal Kanakiya, Compliance Head Vipul Mehta, and Community Manager Adit Sreenivasan. The firm also includes partners like Ryan Ridgway and Ankur Vishwakarma. With offices in key Indian cities like Mumbai, Bengaluru, and Delhi NCR, and a presence in the United States, including Los Angeles and Miami, 2AM VC aims to bridge global capital with Indian innovation, providing crucial access to early-stage deals in the subcontinent.

47th Street Partners is a venture capital firm headquartered in Menlo Park, California, focused on investing in early-stage and seed rounds of emerging technology companies. The firm actively participates in the tech startup ecosystem, providing capital and strategic support to innovative ventures.47th Street Partners emphasizes partnerships with founders and companies that leverage technology to drive growth and transformation. The firm is known for leading investments in technology sectors and has a particular interest in Government Technology (GovTech), artificial intelligence (AI), and software solutions.Founded in 2022 as a Limited Partnership, 47th Street Partners combines deep industry knowledge with a hands-on approach, seeking to help portfolio companies scale effectively. While specific details on assets under management and employee count are not publicly disclosed, the firm's active role in seed and venture rounds highlights its focus on early-stage innovation.The firm’s registered name is 47th Street Partners I-a LP, established in Menlo Park, CA.

500 Global (formerly 500 Startups) is a global venture capital and accelerator firm founded in 2010 by Dave McClure and Christine Tsai. Headquartered in San Francisco with a global presence, the firm supports founders through accelerator programs, mentorship, and capital. The firm manages approximately US $2.3 billion in assets and has backed over 5,000 founders across more than 2,500 startups in over 80 countries. Its portfolio includes more than 30 unicorns and many high-growth companies exceeding US $100 million in valuation. 500 Global specializes in early-stage investments across sectors such as fintech, AI, SaaS, e-commerce, health-tech, and enterprise software. Through programs like its flagship accelerator and VC Unlocked, it equips founders and emerging investors with the knowledge, networks, and tools needed to scale globally.

8VC is a technology and life‑sciences venture capital firm founded in 2015 by Joe Lonsdale, Drew Oetting, Alex Kolicich, and Jake Medwell. Originating in San Francisco and now headquartered in Austin, Texas, the firm brings together operators, technologists, and policy thinkers to invest in startups built to solve deep infrastructure and societal challenges. With over $6 billion in committed capital and a portfolio of more than 350 companies, 8VC invests across pre‑seed through growth stages in areas such as logistics, defense, enterprise software, healthcare, life sciences, manufacturing, financial services, and IT infrastructure. The firm also operates a proprietary “Build” program to launch new companies and a fellowship to attract top talent to its portfolio. Driven by a mission to "fix a broken world," 8VC backs transformative entrepreneurs building long‑term value in sectors often overlooked or deeply entrenched. Notable investments include Anduril, Epirus, Palantir, Guardant Health, and Hyperloop One, reflecting the firm’s belief in principled contrarianism and societal impact.

A.Capital Ventures is a venture capital firm established in 2014, dedicated to investing in early-stage technology companies. The firm's investment strategy is broad, encompassing sectors such as artificial intelligence, decentralized finance, cryptocurrency, business productivity software, and biotechnology. They actively seek opportunities within information technology, software as a service, high tech, blockchain technology, enterprise applications, e-commerce, mobile applications, financial services, software development, communication software, and hardware. A.Capital Ventures is known for its founder-friendly approach, providing capital and strategic connections to entrepreneurs.Founded in 2014 by Ronny Conway, A.Capital Ventures emerged with a mission to support innovative founders. Ronny Conway, a former Partner at Andreessen Horowitz and an early employee at Google Ventures, brought extensive experience in seed and early-stage investing, having been involved in notable investments like Airbnb, Instagram, and Twitter. He is joined by General Partners Ramu Arunachalam, who also previously worked at Andreessen Horowitz focusing on cloud infrastructure and big data, and Kartik Talwar, who led crypto and technical investments at SV Angel. This leadership team brings a wealth of experience from prominent venture capital firms and technology giants.A.Capital Ventures boasts a diverse portfolio of impactful companies. Their notable investments include industry leaders and innovators such as Coinbase, Airbnb, Databricks, Reddit, Notion, Uniswap, Anthropic, Replit, OpenSea, NEAR, Hugging Face, Pinterest, Character.ai, and Stability AI. These investments span various high-growth areas, from cryptocurrency and decentralized finance to AI-powered platforms, collaborative software, and social media. The firm primarily invests in Seed and Series A rounds, with typical deal sizes ranging from $10 million to $50 million.The team at A.Capital Ventures comprises experienced professionals with deep expertise across technology, venture capital, and talent acquisition. Ronny Conway, Ramu Arunachalam, and Kartik Talwar, as General Partners, leverage their backgrounds from Andreessen Horowitz, Google, Google Ventures, and SV Angel to guide portfolio companies. The firm also emphasizes talent support, with dedicated Talent Partners like Carrie Farrell and Brad Goldoor, who previously built recruiting systems at Google and Google Ventures. This integrated approach provides founders with not only capital but also crucial operational and human resources guidance to scale their businesses effectively.

a16z speedrun is an intensive 12-week accelerator program launched by Andreessen Horowitz in 2023, designed to support early-stage founders globally. The program invests up to $1 million in new startups, primarily at the pre-seed and seed stages, with a focus on helping them achieve product-market fit rapidly. It provides direct investment, extensive fundraising support, and connections to a vast network of external investors.The program was established in 2023 by Andreessen Horowitz, a prominent American venture capital firm founded by Marc Andreessen and Ben Horowitz in 2009. Initially, a16z speedrun focused on pre-seed gaming startups, drawing its name from the gaming term "speedrunning" to reflect its emphasis on rapid development. The firm later expanded its scope to encompass a broader range of technology and entertainment startups, including those in AI and creative industries, while maintaining its core ethos of fostering innovation and accelerating growth.Since its inception, a16z speedrun has rapidly scaled, deploying over $180 million to fund more than 150 startups. Notable portfolio companies mentioned include Sekai, Fundamental Research Labs, and k-ID, all of whom have lauded the program's impact on their growth, from securing talent and early design partners to strategic guidance and successful fundraising rounds. The program culminates in a Demo Day, where founders present to a large audience of investors.The a16z speedrun program offers comprehensive coaching and mentorship, including 1:1 sessions with industry leaders and the a16z speedrun team. Key individuals involved include Jon Lai, an integral part of the speedrun team, and Andreessen Horowitz partners like Joshua Lu and Andrew Chen, who provide strategic guidance and mentorship. The program also leverages the broader expertise and network of Andreessen Horowitz, with founders Marc Andreessen and Ben Horowitz participating as speakers and mentors, offering unparalleled access to seasoned operators and a vast ecosystem of resources.

Abingworth is a transatlantic life science investment firm dedicated to transforming breakthrough scientific discoveries into innovative medicines. The firm partners with entrepreneurs and management teams to provide capital and expertise to young biopharma companies across various stages of development. Abingworth employs a flexible investment strategy, encompassing seed and early-stage ventures, development-stage companies, and pioneering approaches such as Venture Investments in Public Equities (VIPEs) and Clinical Co-Development to accelerate drug development and commercialization.The firm was founded in 1973 by London stockbrokers Peter Dicks and Hon. Anthony Montagu, initially as a broader investment firm. Abingworth established its dedicated biotech investment arm in 1987, marking its deep commitment to the life sciences sector. Over its extensive history, Abingworth has raised 15 funds focused on life sciences and healthcare, demonstrating a consistent track record in supporting the growth of innovative companies.Abingworth has invested in over 190 life science companies, contributing to numerous product approvals, IPOs, and M&A transactions. Notable investments include companies like Alnylam Pharmaceuticals, Vaxcyte, Phathom Pharmaceuticals, Median Technologies, and Jasper Therapeutics. The firm's latest investment was in R1 Therapeutics in March 2026. Abingworth was acquired by The Carlyle Group in August 2022, enhancing its capital resources and operational capabilities.The Abingworth team comprises professionals with significant prior experience in life sciences, offering hundreds of years of collective operational expertise. They provide comprehensive support to portfolio companies, assisting with leadership recruitment, drug target selection, business strategy, clinical development plans, and legal navigation. The firm also leverages a broad network of leading scientific and industry advisors to further support its portfolio.

Abstract Ventures is a San Francisco-based venture capital firm with $1.8 billion in assets under management, focusing on seed and early-stage companies. The firm is sector-agnostic, investing in a wide range of industries including biotechnology, consumer products, crypto-blockchain, and enterprise frontier technology. Abstract Ventures is known for its founder-friendly approach, offering not only capital but also extensive connections and strategic support to help portfolio companies succeed.The firm was founded in 2016 by Ramtin Naimi. Naimi began trading tech stocks at age 13 and later founded a hedge fund before transitioning to private market investing. He established Abstract Ventures at the age of 25. The firm's strategy emphasizes a partnership-oriented approach, prioritizing deep relationships with founders over a broad portfolio.Abstract Ventures has made over 500 investments to date, with a portfolio that includes notable companies such as Rippling, Material (which achieved unicorn status in 2022), Solana, WorkOS, and xAI. Their investments span various sectors, including AI & Intelligence (e.g., LangChain, Replit, Cognition), Enterprise Software (e.g., Figma-acquired Dynaboard, Voiceflow), Fintech (e.g., Alpaca, Ripple, Cherry), Healthcare (e.g., Garner, Connie Health), and Frontier Tech (e.g., SpaceX, Halo Industries).The team at Abstract Ventures is spearheaded by founder and General Partner Ramtin Naimi, alongside other partners like Alex Davidov, David Kwon, and Andrei Kozyrev. Caroline Stevenson serves as Operating Partner for Talent, and Anthony Heckman as Operating Partner for GTM. The team leverages years of investment experience and market insight, providing extensive support and mentorship to their portfolio companies.

Accenture Ventures is the corporate venture capital arm of Accenture plc, a global professional services company. Established in 2015, the firm focuses on making strategic investments in early- and growth-stage technology companies. Its primary objective is to identify and partner with startups developing innovative enterprise and industry-focused technologies, integrating their capabilities into Accenture's extensive services and client solutions. This approach emphasizes strategic impact and accelerating product-market fit for its portfolio companies, leveraging Accenture's vast global client base and deep industry expertise.The firm's investment thesis centers on technologies that drive digital transformation and enhance enterprise capabilities. Key areas of focus include artificial intelligence (AI), cloud computing, cybersecurity, blockchain, data and analytics, and digital engineering. Accenture Ventures actively seeks out companies that can provide vertical AI solutions tailored to specific sectors such as financial services, healthcare, manufacturing, retail, and the public sector. They also explore emerging trends like physical AI and robotics, aiming to bridge the gap between groundbreaking ideas and scalable enterprise solutions.Accenture Ventures manages a $250 million fund and has made over 70 active venture investments. Notable portfolio companies include Replit, a platform for developing and deploying applications with AI; Sanctuary AI, a developer of AI-powered general-purpose robots; Open Cosmos, an operator of space missions providing satellite data; and Pixxel, which offers hyperspectral imaging satellites. The firm typically invests in Series A and Series B rounds, supporting startups through various stages of growth.The team at Accenture Ventures includes experienced professionals such as Tom Lounibos, Avnish Sabharwal, and Joe Lui. They bring a wealth of knowledge in technology and venture capital, working closely with portfolio companies to provide not just capital, but also strategic guidance, market access to Fortune Global 500 clients, and opportunities for co-innovation. The firm's global mandate allows it to invest across continents, emphasizing execution and local market understanding to support diverse innovation hubs.

Adapt Nation Capital is a venture capital firm dedicated to investing in entrepreneurs who are accelerating the transition towards a sustainable and healthy future. The firm's core philosophy, encapsulated in its 'adapt' and 'nation' ethos, emphasizes the need for resilience to acute planetary conditions and a community-driven approach to addressing global challenges like climate change and pandemics. They seek out innovative solutions that empower communities to thrive amidst these complex issues.The firm focuses its investments primarily within the climate sector, supporting companies that offer tangible solutions for environmental sustainability. This includes technologies for carbon removal, renewable energy integration, waste recycling, and tools that facilitate a decarbonized economy. Adapt Nation Capital aims to provide capital to scale impactful ideas, contributing to a more resilient and environmentally conscious global landscape.Adapt Nation Capital's portfolio showcases a diverse range of companies tackling various aspects of sustainability. Notable investments include AIRMYNE, which is developing direct air capture systems for carbon dioxide removal; Critical Loop, focused on mobilizing batteries to enhance renewable energy usage; and DESCYCLE, specializing in recycling valuable metals from electronic waste. Other key portfolio companies are DOVETAIL, providing data and tools for investors navigating the decarbonized economy; EQO, evaluating aquatic ecosystem health; GLASS DYENAMICS, offering energy-efficient glass solutions for buildings; and INFYOS, creating supply chain sustainability tools for the battery market.While specific details about the founding team and their individual expertise are not publicly detailed, the firm's investment strategy clearly reflects a deep understanding of and commitment to the cleantech, climatech, and environmental sectors. Their focus on supporting innovative solutions across various stages of development indicates a team capable of identifying and nurturing high-potential ventures in these critical areas.

Adverb Ventures is an early-stage venture capital firm that partners with founders to build enduring, breakout companies; the firm emphasizes how companies are built — “the adverbs matter as much as the verbs.”Founded by former operators and investors with product and leadership experience at companies such as Twitter, Slack, and Robinhood, Adverb runs programming and community events for founders and curates an operator-led approach to support portfolio teams.The firm’s portfolio includes companies across AI, enterprise software and consumer technology (examples listed on their site include Cove, Hypernatural, Shotsy, Outset AI and others), and it actively convenes founders through events, retreats and newsletters to deepen founder connections and operational support.

AE Industrial Partners (AEI) is a private equity firm specializing in control investments in aerospace, defense & government services, space, power & utility services, and industrial technology. Founded by experienced industry executives, AEI brings deep operational expertise and strategic resources to its portfolio companies, focusing on accelerating growth, innovation, and long-term value creation. AEI’s investment philosophy centers around partnering with management teams to transform and scale businesses in highly technical and regulated sectors. The firm’s team combines financial acumen with sector-specific insight to identify and build companies that are well-positioned to lead in their markets. AEI typically targets companies with strong engineering capabilities, defensible market positions, and opportunities for operational enhancement or strategic consolidation. With headquarters in Boca Raton, Florida, and offices in Washington D.C. and Los Angeles, AE Industrial Partners is active across North America. The firm manages multiple funds and strategies, including private equity, venture capital, and structured capital solutions, allowing for flexibility across the capital stack. AEI has earned a reputation as a leading investor in the aerospace and defense ecosystem.

Aglaé Ventures is a technology-focused investment firm created to fund and support ambitious founders building fast-growing, asset-light companies. Backed by Agache (formerly Groupe Arnault), the principal investment vehicle of Bernard Arnault, it operates from Paris with offices in New York and San Francisco. The firm invests broadly across stages — from seed and Series A through Series B to pre-IPO — and deploys ticket sizes from approximately €100K (seed) up to €100M (growth/pre-IPO), targeting marketplaces, software (SaaS and open-source), content and consumer platforms, developer and app tools, and digitally native vertical brands among other asset-light models. Aglaé emphasizes long-term capital, operational support (growth management, brand building, digital marketing, and global expansion), and access to an extensive network including the LVMH ecosystem and global tech founders and investors to help portfolio companies scale globally.

AICONIC Ventures is a venture capital firm specializing in early-stage investments across artificial intelligence (AI) and deep technology. The firm focuses on groundbreaking innovations from Pre-seed to Series B, with a strategic emphasis on bridging the technological advancements emerging from the US, particularly Silicon Valley, with global markets, especially in Asia. Their investment thesis centers on identifying and nurturing category-defining AI companies that are highly technical and driven by deep research, aiming to help these startups achieve global scale and reach through their extensive network of customers and investors in Asia.Founded in 2025, AICONIC Ventures was launched by Mukaya (Tai) Panich, who serves as the CIO and Managing Partner. Panich brought over 20 years of experience in the technology sector and previously led SCB 10X, a corporate venture capital fund, for over five years. The firm was established with an initial fund close of $200 million, with a target of $250 million, and aims to capitalize on the ongoing fourth industrial revolution driven by generative AI.The firm's portfolio showcases a diverse range of innovative companies, including Corintis, which focuses on bio-inspired in-chip cooling, Sophont, a developer of state-of-the-art pathology foundation models, and eBots, a company enabling viable and competitive onshoring manufacturing in the US. Other notable investments span areas such as novel power management ICs for AI data centers, versatile robots for adaptive manufacturing, next-generation photonics, autonomous AI agents, game-changing liquid cooling for AI chips, preemptive cybersecurity, and universal multimodal foundation models for healthcare.The AICONIC Ventures team comprises seasoned professionals with deep technical and business expertise. Mukaya (Tai) Panich, with her background in semiconductor startups and extensive investment experience, leads the firm. Advisors like Lip-Bu Tan, former CEO of Intel and founding managing partner of Walden Catalyst, and Amarjit Gill, a co-founder of multiple successful tech companies acquired by industry giants, provide invaluable guidance. The team also includes Thanapong (Mod) Boontaeng as CTO, focusing on technical due diligence and AI tech stack evaluation, and Kaweepol (Kevin) Panpheng as Partner, bringing quantitative rigor to deal evaluation.

AJU IB Investment is a prominent South Korean venture capital and private equity firm, established in 1974 as the nation's first venture capital company. The firm has a long-standing track record of supporting innovative companies across various stages of their lifecycle, from early-stage startups to pre-IPO and post-IPO phases. With a cumulative managed fund exceeding KRW 3.2 trillion over the past two decades, AJU IB Investment demonstrates both stability and profitability, having successfully liquidated 38 funds. They are also pioneers in South Korea for endorsing the TCFD and adopting an ESG investment approach since 2021, emphasizing a sustainable venture ecosystem.The firm's investment strategy is multi-faceted, encompassing venture capital and private equity investments. While AJU IB Investment broadly targets sectors such as healthcare, technology, information technology (including mobile service platforms, software, semiconductors, and AI), biotechnology, life science, and environment sectors, its U.S. subsidiary, Solasta Ventures, has a more specialized focus. Solasta Ventures, incorporated in 2019 from AJU IB Investment's Americas office established in 2013, primarily invests in pharmaceutical and biotech startups from its Boston headquarters, with a Silicon Valley branch focusing on AI, cloud, big data, robotics, and autonomous driving.AJU IB Investment and its subsidiary Solasta Ventures actively seek to invest in companies that advance the standard of care for diseases with unmet medical needs, leveraging deep scientific expertise and an extensive network. Their portfolio includes investments in therapeutics, drug development, cell therapy, and genetic medicines, with a particular interest in oncology, neurology, and immunology. Solasta Ventures has shown impressive investment results, with 19 of its 38 invested companies being listed on NASDAQ by June 2023, acting as a crucial bridge between American startups and Korean companies.The leadership team includes Jiwon Kim as the CEO of AJU IB Investment, overseeing the firm's comprehensive investment strategies. Derek Yoon serves as the President & CEO of Solasta Ventures, leading its U.S. investments with a focus on life science companies and early-stage startups with novel science. The team's collective experience in healthcare investments and drug development, coupled with a scientific advisory board, underpins their ability to identify and nurture promising ventures globally.

Alexandria Venture Investments is the strategic venture capital arm of Alexandria Real Estate Equities, Inc., a leading developer of life science and technology campuses. With deep roots in the biotech and healthcare sectors, the firm invests in transformative early- to growth-stage companies that are shaping the future of life sciences, diagnostics, digital health, and agtech. The firm leverages its unique position within Alexandria's ecosystem to provide more than just capital—it offers access to cutting-edge facilities, industry expertise, and a vast network of scientific and corporate leaders. Alexandria Venture Investments is known for its active partnership model, working closely with founders and management teams to accelerate innovation and growth. Focused on advancing solutions that address critical global health challenges, the firm targets companies with strong scientific foundations and scalable platforms. Its portfolio includes some of the most promising startups and industry leaders across North America and select global markets.